Trials / Sponsors / Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA
Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | A Study of Efficacy, Safety, and Tolerability of KAN-101 in People With Celiac Disease Celiac Disease, Coeliac Disease | Phase 2 | 2023-12-13 |
| Terminated | A Study of Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of KAN-101 in Celiac Disease (ACeD-it) Celiac Disease | Phase 1 / Phase 2 | 2022-11-15 |
| Completed | Assessment of KAN-101 in Celiac Disease (ACeD) Celiac Disease | Phase 1 | 2020-01-21 |